The largest database of trusted experimental protocols

4 protocols using pgp glo assay

1

Evaluating PEGylated Vitamin E Effects on P-gp ATPase

Check if the same lab product or an alternative is used in the 5 most similar protocols
P-gp is an ATP-dependent drug efflux pump that plays an important role in multi-drug resistance and drug bioavailability. The effect of the PEGylated vitamin E isomers on the P-gp ATPase activity was carried out by the Pgp-Glo™ assay (Promega Corporation, Madison, WI). The Pgp-Glo™ assay detects the effects of compounds on recombinant human P-gp in a cell membrane fraction. The assay relies on the ATP-dependent light-generating reaction of firefly luciferase where an increase in luminescence is indicative of the inhibitory effect of compounds on the P-gp ATPase enzyme. PEGylated vitamin E isomers at a final concentration of 10 to 100 μM in assay buffer were added to the wells of a white 96-well plate containing 20 μL (0.5 mM) verapamil, which was required to activate P-gp ATPase (Collnot et al., 2007 (link)). The reaction was initiated by adding Mg ATP (25 mM) to each well. The plate was placed on a shaker for 5 min and then incubated for 40 min at 37 °C. The reaction was stopped by adding 50 μL of the ATP detection reagent. After addition, the plate was left at room temperature for 20 min to allow for the luminescent signal to develop. Luminescence was measured using a Synergy 2 Multi-Mode BioTek plate reader (BioTek Instruments, Inc. Winooski, VT).
+ Open protocol
+ Expand
2

Evaluating P-gp ATPase Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The P-gp ATPase activity was evaluated with the P-gp-Glo™ assay (Promega, Co., USA). According to the kit instructions, a series of working solution with P-gp membranes, MgATP and different NanoDDSs at the same Au concentration of 10 μM were prepared in advance and added into the 96-well plate in sequence. Verapamil and sodium orthovanadate were set as positive and negative group, respectively, and all the readings were normalized by the subtraction of negative group.22 (link),23 (link) After incubation at 37 °C for 40 min, the mixture was collected and centrifuged at 12000 rpm for 5 min then rejoined into the 96-well plate. 50 μL of ATP detection reagent was added in each detection well and incubated for an additional 20 min, followed by the luminescence measurement.
+ Open protocol
+ Expand
3

Synthesis and Evaluation of Isatin Derivatives

Check if the same lab product or an alternative is used in the 5 most similar protocols
5,7-Dibromoisatin (1) and the N-alkylated derivatives 5,7-dibromo-N-(p-hydroxymethylbenzyl)isatin (2); 5,7-dibromo-N-(p-phenylbenzyl)isatin (3); 5,7-dibromo-N-(p-cinnamyl)isatin (4) and 5,7-dibromo-N-(-naphthalen-1-ylmethyl)isatin (5) were synthesized as described previously [25 (link), 26 (link)]. Vinblastine sulfate, colchicine, paclitaxel, doxorubicin, rhodamine-123, calcein-AM, cyclosporine A, verapamil, anti-P-gp monoclonal antibody F4 and FITC-conjugated goat anti-mouse IgG were purchased from Sigma-Aldrich (Australia). The Pgp-Glo™ assay and CellTiter 96 AQueous One Solution Cell Proliferation Assay (MTS) were purchased from Promega Corporation (Australia).
+ Open protocol
+ Expand
4

Permeability Assay for Drug Transport

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hank’s balanced salt solution (HBSS), 2-(N-morpholino) ethanesulfonic acid hydrate (MES), N-(2-hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid) (HEPES), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT), fluorescein isothiocyanate-conjugated dextran 4 kDa (FD-4), verapamil, [3H]-digoxin, mucin from porcine stomach type III, ML-7 (an MLCK inhibitor), RO-318220 (a PKC inhibitor), genistein (a tyrosine kinase inhibitor), Na+/K+ ATPase and 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The clear-sol I scintillation cocktail and protease inhibitor cocktail were from Nacalai Tesque (Kyoto, Japan). The P-gp-Glo™ assay and P-gp antibody were obtained from Promega (Madison, WI, USA) and Alexis Biochemicals (San Diego, CA, USA), respectively. Primary antibodies against zonula occludens-1 (ZO-1) and occludin were from Invitrogen (San Diego, CA, USA). Goat anti-mouse IgG H&L Alexa Fluor® 488 and 568 secondary antibodies, FITC-labeled anti-P-gp [UIC2] monoclonal antibody and horseradish peroxidase (HRP)-conjugated secondary antibody were obtained from Abcam (Cambridge, UK). All other chemical reagents were analytical grades.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!